Tetlow L C, Adlam D J, Woolley D E
University Department of Medicine, Manchester Royal Infirmary, The University of Manchester, UK.
Arthritis Rheum. 2001 Mar;44(3):585-94. doi: 10.1002/1529-0131(200103)44:3<585::AID-ANR107>3.0.CO;2-C.
To examine by immunohistochemistry the relative distributions of 6 matrix metalloproteinases (MMPs 1, 2, 3, 8, 9, and 13) and the 2 proinflammatory cytokines interleukin-1beta (IL-1beta) and tumor necrosis factor alpha (TNFalpha) in osteoarthritic (OA) cartilage compared with normal, age-matched articular cartilage.
Articular cartilage samples were obtained from the tibial plateau of OA knees removed at arthroplasty and from normal, nonarthritic, knees obtained at autopsy. Specimens were promptly fixed in Carnoy's fixative, processed, embedded in paraffin, sectioned, and examined by immunohistochemistry for MMP and cytokine production. In addition, human articular chondrocytes (HAC) were treated in vitro with either IL-1beta, TNFalpha, or phorbol myristate acetate (PMA) to assess their potential to produce each of the MMPs, as determined by Western blotting and gelatin zymography.
Immunodetection of the collagenases (MMPs 1, 8, and 13) and stromelysin 1 (MMP-3) was demonstrated in a proportion of chondrocytes in the superficial zone of almost all of the OA specimens that had degenerative matrix changes. The gelatinases (MMPs 2 and 9) were also demonstrated by immunohistochemistry but were not so prominent. IL-1beta- and TNFalpha-positive chondrocytes were also observed in a proportion of cells in the superficial zones of OA specimens. Much less immunostaining for MMPs and cytokines was observed in the deep zone of all OA specimens, where the cartilage matrix and chondrocyte morphology appeared normal. In contrast, full-thickness normal cartilage specimens showed virtually no immunostaining for these MMPs or cytokines. Confirmation that chondrocytes can produce these 6 MMPs was obtained from HAC cultures treated with either IL-1beta, TNFalpha, or PMA; conditioned medium from activated HAC contained all the MMPs demonstrated by immunohistochemistry. Dual immunolocalization studies of OA cartilage specimens demonstrated the coexpression of IL-1 with MMP-8 by individual chondrocytes in situ.
These results indicate that the superficial zone of OA cartilage specimens, which is characterized by fibrillations, chondrocyte clusters, and degenerative matrix changes, contains a variable proportion of cells that immunostain for IL-1beta, TNFalpha, and 6 different MMPs. These observations support the concept that cytokine-MMP associations reflect a modified chondrocyte phenotype and an intrinsic process of cartilage degradation in OA.
通过免疫组织化学方法,研究与正常、年龄匹配的关节软骨相比,骨关节炎(OA)软骨中6种基质金属蛋白酶(MMPs 1、2、3、8、9和13)以及2种促炎细胞因子白细胞介素-1β(IL-1β)和肿瘤坏死因子α(TNFα)的相对分布情况。
关节软骨样本取自关节置换术中切除的OA膝关节的胫骨平台,以及尸检获得的正常、非关节炎膝关节。样本立即用卡诺氏固定液固定,进行处理,石蜡包埋,切片,并通过免疫组织化学检测MMP和细胞因子的产生情况。此外,用人关节软骨细胞(HAC)体外分别用IL-1β、TNFα或佛波酯(PMA)处理,以评估其产生每种MMP的潜力,通过蛋白质免疫印迹法和明胶酶谱法进行测定。
在几乎所有具有退行性基质变化的OA标本的表层区域的一部分软骨细胞中,检测到胶原酶(MMPs 1、8和13)和基质溶解素1(MMP-3)的免疫反应。免疫组织化学也证实了明胶酶(MMPs 2和9)的存在,但不那么明显。在OA标本表层区域的一部分细胞中也观察到IL-1β和TNFα阳性软骨细胞。在所有OA标本的深层区域,软骨基质和软骨细胞形态看起来正常,MMP和细胞因子的免疫染色要少得多。相比之下,全层正常软骨标本对这些MMP或细胞因子几乎没有免疫染色。在用IL-1β、TNFα或PMA处理的HAC培养物中证实软骨细胞可以产生这6种MMP;活化的HAC的条件培养基中含有免疫组织化学显示出的所有MMP。对OA软骨标本的双重免疫定位研究表明,原位单个软骨细胞中IL-1与MMP-8共表达。
这些结果表明,OA软骨标本的表层区域以纤维化、软骨细胞簇和退行性基质变化为特征,含有不同比例的对IL-1β、TNFα和6种不同MMP进行免疫染色的细胞。这些观察结果支持细胞因子-MMP关联反映OA中软骨细胞表型改变和软骨降解内在过程的概念。